- Home
- NCSM vs ADAP Comparison
NCSM vs ADAP Comparison
Compare NCSM & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- ADAP
- Stock Information
- Founded
- NCSM 2006
- ADAP 2008
- Country
- NCSM United States
- ADAP United Kingdom
- Employees
- NCSM N/A
- ADAP 506
- Industry
- NCSM Oilfield Services/Equipment
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- ADAP Health Care
- Exchange
- NCSM Nasdaq
- ADAP Nasdaq
- Market Cap
- NCSM 61.1M
- ADAP 75.5M
- IPO Year
- NCSM 2017
- ADAP 2015
- Fundamental
- Price
- NCSM $31.44
- ADAP $0.29
- Analyst Decision
- NCSM
- ADAP Strong Buy
- Analyst Count
- NCSM 0
- ADAP 5
- Target Price
- NCSM N/A
- ADAP $1.83
- AVG Volume (30 Days)
- NCSM 9.4K
- ADAP 777.8K
- Earning Date
- NCSM 04-30-2025
- ADAP 05-13-2025
- Dividend Yield
- NCSM N/A
- ADAP N/A
- EPS Growth
- NCSM N/A
- ADAP N/A
- EPS
- NCSM 3.27
- ADAP N/A
- Revenue
- NCSM $168,704,000.00
- ADAP $178,032,000.00
- Revenue This Year
- NCSM $7.03
- ADAP N/A
- Revenue Next Year
- NCSM $5.82
- ADAP $69.81
- P/E Ratio
- NCSM $9.66
- ADAP N/A
- Revenue Growth
- NCSM 18.16
- ADAP 195.34
- 52 Week Low
- NCSM $15.90
- ADAP $0.20
- 52 Week High
- NCSM $38.95
- ADAP $1.48
- Technical
- Relative Strength Index (RSI)
- NCSM 52.40
- ADAP 51.38
- Support Level
- NCSM $29.15
- ADAP $0.30
- Resistance Level
- NCSM $32.71
- ADAP $0.32
- Average True Range (ATR)
- NCSM 1.84
- ADAP 0.02
- MACD
- NCSM 0.26
- ADAP 0.01
- Stochastic Oscillator
- NCSM 38.99
- ADAP 67.44
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.